Valuation: SoftOx Solutions AS

Market Cap 223M 23.45M 20.28M 18.94M 17.38M 32.68M 2.23B 33.2M 222M 87.23M 1.12B 88.06M 86.13M 3.7B P/E 2024
-0.64x
P/E 2025 -19.4x
Enterprise Value 203M 21.37M 18.48M 17.26M 15.83M 29.78M 2.03B 30.25M 202M 79.48M 1.02B 80.23M 78.48M 3.37B EV / Sales 2024
2.12x
EV / Sales 2025 12.2x
Free-Float
62.79%
Yield 2024 *
-
Yield 2025 -

Last Transcript: SoftOx Solutions AS

Manager TitleAgeSince
Chief Executive Officer - 2024-08-31
Director of Finance/CFO - -
Corporate Officer/Principal - 2025-12-31
Director TitleAgeSince
Director/Board Member - -
Chairman - -
Director/Board Member 58 2025-06-26
Change 5-day change 1-year change 3-year change Capi.($)
-2.36%+3.33% - - 23.45M
+8.49%+20.55%+70.77%+110.32% 68.12B
+1.25%+2.44%+34.27%+70.43% 55.18B
-1.09%+32.96%+19.67%+494.56% 28.63B
+10.83%+18.38%+56.20%+6.03% 23.99B
+2.72%+3.41%-16.11%-7.96% 23.53B
+6.50%+7.56%+44.65%-21.73% 18.45B
+6.20%+11.51%+33.87%+693.38% 16.44B
-3.88%+16.98%+199.30%+359.77% 15.83B
+3.58%+1.96%+43.35%+163.76% 13.4B
Average +3.22%+11.68%+54.00%+207.62% 29.28B
Weighted average by Cap. +4.36%+13.10%+50.69%+168.47%

Financials

2024 2025
Net sales 7.91M 833K 721K 673K 617K 1.16M 79.3M 1.18M 7.9M 3.1M 39.75M 3.13M 3.06M 131M 15.58M 1.64M 1.42M 1.33M 1.22M 2.29M 156M 2.32M 15.55M 6.1M 78.27M 6.16M 6.03M 259M
Net income -42.94M -4.52M -3.91M -3.65M -3.35M -6.3M -430M -6.4M -42.85M -16.82M -216M -16.98M -16.61M -713M -10.81M -1.14M -985K -920K -844K -1.59M -108M -1.61M -10.79M -4.24M -54.31M -4.28M -4.18M -180M
Net Debt -10.51M -1.11M -957K -894K -820K -1.54M -105M -1.57M -10.49M -4.12M -52.8M -4.16M -4.07M -175M -19.79M -2.08M -1.8M -1.68M -1.54M -2.9M -198M -2.95M -19.75M -7.75M -99.42M -7.83M -7.66M -329M
Logo SoftOx Solutions AS
SoftOx Solutions AS is a Norway-based medtech and biotech company, that develops products to help fight infections from viruses, biofilm resistance and antimicrobial resistance. It is a developer of infection control solutions for disinfection, wound care and the respiratory tract. The current business segments can be divided into: Wounds, Disinfection and Respiratory. SoftOx Solutions is engaged in the development of a range of products that can be classified as either medical devices or medicinal products for human use. SoftOx’s product portfolio includes such products as SafeDes+, a hand disinfectant for irritated, compromised and eczematous skin. The Company has several subsidiaries, including SoftOx Disinfection AS, SoftOx Defense Solutions AS and SoftOx Denmark AS.
Employees
-